US 12,121,558 B2
Liver activation nanoemulsion and toxin excretion enhancement method
Christopher W. Shade, Lafayette, CO (US); and Steven Tieu, Louisville, CO (US)
Assigned to Quicksilver Scientific, Inc., Louisville, CO (US)
Filed by Quicksilver Scientific, Inc., Louisville, CO (US)
Filed on Jan. 26, 2022, as Appl. No. 17/584,661.
Application 17/584,661 is a division of application No. 16/849,654, filed on Apr. 15, 2020, granted, now 11,291,702.
Claims priority of provisional application 62/834,013, filed on Apr. 15, 2019.
Prior Publication US 2022/0265748 A1, Aug. 25, 2022
Int. Cl. A61K 36/288 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 31/355 (2006.01); A61K 31/381 (2006.01); A61K 31/404 (2006.01); A61K 36/328 (2006.01); A61K 36/515 (2006.01); A61K 47/14 (2017.01); A61K 47/44 (2017.01); B82Y 5/00 (2011.01)
CPC A61K 36/288 (2013.01) [A61K 9/0053 (2013.01); A61K 9/1075 (2013.01); A61K 31/355 (2013.01); A61K 31/381 (2013.01); A61K 31/404 (2013.01); A61K 36/328 (2013.01); A61K 36/515 (2013.01); A61K 47/14 (2013.01); A61K 47/44 (2013.01); B82Y 5/00 (2013.01)] 39 Claims
 
1. An intra-oral, nanoemulsion blend for enhancing liver performance in animals when orally administered, the blend comprising:
a milk thistle, diindolylmethane, quercetin, and luteolin first delivery means for simultaneously delivering milk thistle, diindolylmethane, quercetin, and luteolin to the bloodstream of an animal, where the milk thistle, diindolylmethane, quercetin, and luteolin delivery means comprises at least one amphiphilic fat, a polyethylene glycol surfactant, and an associating oil,
where a ratio of the amphiphilic fat to the polyethylene glycol surfactant is from 1:1.8 to 1:3 by weight;
a myrrh, dandelion, gentian, and goldenrod second delivery means for simultaneously delivering myrrh, dandelion, gentian, and goldenrod to the bloodstream of an animal, where the myrrh, dandelion, gentian, and goldenrod delivery means comprises the at least one amphiphilic fat and the polyethylene glycol surfactant;
an R-lipoic acid delivery means for delivering R-lipoic acid to the bloodstream of an animal, the R-lipoic acid delivery means comprising the at least one amphiphilic fat; and
a liquid carrying means for carrying the first and second delivery means, where the liquid carrying means comprises ethanol and glycerin;
where
the blend is a stable dispersion that is transparent, and
the first delivery means and the second delivery means have an average particle diameter from 10 to 100 nanometers as carried by the liquid carrying means.